Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon in Adults With Chronic Insomnia
NCT00671567Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2002
- Primary completion
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ramelteon in Insomnia (3 arms), sponsored by Takeda. Primary endpoint: Mean Subjective Sleep Latency at Week 1. Started Dec 2002; status: completed.
02
Drugs
ramelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00671567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00671567.